Soft quaternary anticholinergics: Comprehensive quantitative structure-activity relationship (QSAR) with a linearized biexponential (LinBiExp) model

被引:16
作者
Buchwald, P
Bodor, N
机构
[1] IVAX Res Inc, Miami, FL 33137 USA
[2] Univ Florida, Hlth Sci Ctr, Ctr Drug Discovery, Gainesville, FL 32610 USA
关键词
D O I
10.1021/jm050679n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A comprehensive quantitative structure-activity relationship (QSAR) study is presented for quaternary soft anticholinergics including two distinctly different classes designed on the basis of the soft analogue and the inactive metabolite approaches. Because of the clear biphasic (bilinear) nature of the activity data when all structures (n = 76) were considered as a function of molecular size (volume), a nonlinear model had to be used, and a linearized biexponential (LinBiExp) model proved very adequate. LinBiExp can fit activity data that show a maximum (or a minimum) around a given parameter value but tend to show linearity away from this turning point. Contrary to Hansch-type parabolic models, LinBiExp represents a natural extension of linear models, and a direct correspondence between its parameters and those obtained earlier by linear regression on compound subsets covering more limited parameter ranges could be easily established. Stereospecificity was confirmed as important, and the presence of an acid moiety was found to essentially eliminate activity. The consideration of bilinear behavior, which most likely results from size limitations at the binding site, can also explain the embarrassingly low activity found for a relatively large compound predicted as highly active by Lien, Ariens, and co-workers based on their QSAR study.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 72 条
[61]   DISTINCT PRIMARY STRUCTURES, LIGAND-BINDING PROPERTIES AND TISSUE-SPECIFIC EXPRESSION OF 4 HUMAN MUSCARINIC ACETYLCHOLINE-RECEPTORS [J].
PERALTA, EG ;
ASHKENAZI, A ;
WINSLOW, JW ;
SMITH, DH ;
RAMACHANDRAN, J ;
CAPON, DJ .
EMBO JOURNAL, 1987, 6 (13) :3923-3929
[62]   Cyclohexylmethylpiperidinyltriphenylpropioamide:: A selective muscarinic M3 antagonist discriminating against the other receptor subtypes [J].
Sagara, Y ;
Sagara, T ;
Mase, T ;
Kimura, T ;
Numazawa, T ;
Fujikawa, T ;
Noguchi, K ;
Ohtake, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :984-987
[63]   ESTIMATING DIMENSION OF A MODEL [J].
SCHWARZ, G .
ANNALS OF STATISTICS, 1978, 6 (02) :461-464
[64]   COMPARATIVE STUDY ON THE EFFECT OF ANTICHOLINERGIC COMPOUNDS ON SWEATING [J].
SHELLEY, WB ;
HORVATH, PN .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1951, 16 (04) :267-274
[65]   TOPICAL SUPPRESSION OF ECCRINE SWEAT DELIVERY WITH A NEW ANTICHOLINERGIC AGENT [J].
STOUGHTON, RB ;
CHIU, F ;
FRITSCH, W ;
NURSE, D .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1964, 42 (01) :151-155
[66]   Antagonist binding in the rat muscarinic receptor - A study by docking and X-ray crystallography [J].
Tanczos, AC ;
Palmer, RA ;
Potter, BS ;
Saldanha, JW ;
Howlin, BJ .
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2004, 28 (5-6) :375-385
[67]   The role of long-acting bronchodilators in the management of stable COPD [J].
Tashkin, DP ;
Cooper, CB .
CHEST, 2004, 125 (01) :249-259
[68]   N-ALKYL-NOR-TROPINE ESTERS OF 2-PHENYL-CYCLOHEXENIC ACIDS AS NEW BRONCHODILATOR AGENTS - EFFECT OF STRUCTURAL AND CONFORMATIONAL MODIFICATIONS ON AFFINITY FOR MUSCARINIC RECEPTORS [J].
TURBANTI, L ;
CERBAI, G ;
GARZELLI, G ;
RENZETTI, AR ;
CRISCUOLI, M ;
SUBISSI, A ;
BRAMANTI, G ;
MARTINELLI, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (05) :449-462
[69]   Improving the oral efficacy of CNS drug candidates:: Discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists [J].
Wang, YG ;
Chackalamannil, S ;
Hu, ZY ;
Greenlee, WJ ;
Clader, J ;
Boyle, CD ;
Kaminski, JJ ;
Billard, W ;
Binch, H ;
Crosby, G ;
Ruperto, V ;
Duffy, RA ;
Cohen-Williams, M ;
Coffin, VL ;
Cox, KA ;
Grotz, DE ;
Lachowicz, JE .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) :5415-5418
[70]   EXACERBATION OF AKINETIC SEIZURES BY ATROPINE EYE DROPS [J].
WRIGHT, BD .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1992, 76 (03) :179-180